First in vivo gene-editing drugs enter the clinic Sangamo Therapeutics has started dosing patients with gene-editing drugs that are administered directly into the blood.

Para acessar a publicação na íntegra clique aqui

Click here to original publication.

Fonte: NATURE REVIEWS | DRUG DISCOVERY VOLUME 17 | JANUARY 2018